A Quality Improvement Plan for Hypertension Control

Brief Summary

Official Title: “A Quality Improvement Plan for Hypertension Control: the INCOTECA Project”

The study hypothesis is that the implementation of a plan for quality improvement at the primary care health teams taking care of hypertensive patients, will increase the level of blood pressure control among those patients.

  • Study Type: Interventional
  • Study Design: Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research
  • Study Primary Completion Date: April 2007

Detailed Clinical Trial Description

The study is to compare the results on the hypertension control between two groups of primary health care teams. The intervention group will undertake a quality improvement plan for hypertension control, in which the following aspects will be included in the intervention:

Specific training programme on how to diagnose hypertension , and measure blood pressure correctly To send feed back information to primary care health professionals about poorly controlled hypertensive patients An audit will be performed, every 6 months, to see the adhesion to the recommended clinical guidelines , and the information will be diffused among the participant primary health care professionals Each participant primary health care team will have a designated reference person, that will provide support on any doubts on the programme implementation.

The non intervention group will follow hypertensive patients following the same clinical practice guide as the intervention group, with no intervention on the primary health care professionals

Interventions Used in this Clinical Trial

  • Other: Quality Improvement plan for Hypertension Control
    • Implementation of a plan of quality improvement addressed to health professionals in Primary Health Care Teams. It includes: Specific training programme on how to diagnose hypertension , and measure blood pressure correctly To send feed back information to primary care health professionals about poorly controlled hypertensive patients An audit will be performed, every 6 months, to see the adhesion to the recommended clinical guidelines , and the information will be diffused among the participant primary health care professionals Each participant primary health care team will have a designated reference person, that will provide support on any doubts on the programme implementation

Arms, Groups and Cohorts in this Clinical Trial

  • Experimental: quality improvement plan
    • It will be the group of primary health care teams who will undertake the quality improvement plan for hypertensive patients
  • No Intervention: non intervention
    • It will be the group of primary health care teams that will not undertake the quality improvement plan for hypertension control

Outcome Measures for this Clinical Trial

Primary Measures

  • good control of hypertension as a dichotomous variable, based on systolic blood pressure and diastolic blood pressure records over the last 12 months
    • Time Frame: every three months, for a whole year
      Safety Issue?: No

Secondary Measures

  • treatment with antihypertensive drugs, number of antihypertensive drugs, assessment of therapeutic compliance
    • Time Frame: every three months, for a whole year
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria

  • Patients diagnosed with hypertension before January 1st, 2006
  • Patients assigned at the primary health team participating, and with clinical electronic records

Exclusion Criteria

  • Patients diagnosed with hypertension after January 1st, 2006
  • Patients under 18 years of age
  • Patients with a diastolic blood pressure higher than systolic blood pressure as recorded in the clinical records

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial: No

Clinical Trial Investigator Information

  • Lead Sponsor
    • Jordi Gol i Gurina Foundation
  • Provider of Information About this Clinical Study
    • Roser VallésFernández, Institut Català de la Salut
  • Overall Official(s)
    • Roser Valles Fernandez, Principal Investigator, Institut Català de la salut

Source

Clinical Trials content is provided directly by the US National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of information about a specific clinical trial contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00820183